Quince Therapeutics Cash Flow Statement (2018-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-21.75M	-21.71M	66.55M	-21.64M	-16.56M	-7.92M	-5.53M	-12.25M	-4.89M	-5.35M	-8.89M	-11.15M	-27.73M	-5.49M	-12.46M	-15.03M	-16.05M	-13.44M	-19.28M	35.91M
Share-based Compensation (Quarter)	6.75M	7.62M	8.49M	9.24M	5.05M	0.69M	1.63M	1.48M	3.90M	3.80M	1.09M	1.27M	0.20M	0.10M	4.51M	1.39M	0.10M	0.01M	5.11M	9.30M
Gains from Investment Securities (Quarter)											1.58M	2.54M	2.22M	-2.68M			0.53M	2.10M	16.98M	-64.33M
Asset Writedowns and Impairment (Quarter)						0.04M		0.07M												67.81M
Cash from Operations (Quarter)	-17.56M	-17.34M	-14.42M	-16.09M	-15.41M	-6.70M	-5.83M	-3.57M	-3.83M	-4.82M	-6.08M	-8.35M	-8.74M	-7.26M	-7.55M	-9.60M	-11.41M	-9.93M	-10.48M	-7.63M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Depreciation & Amortization (CF) (Quarter)	0.09M	0.09M	0.08M	0.04M	0.08M	0.04M	0.04M	0.02M	0.00M		0.30M	0.04M	0.04M	0.09M	0.02M	0.03M	0.04M	0.04M	0.04M	0.04M
Change in Working Capital
Change in Account Payables (Quarter)	4.35M	-4.31M	2.03M	-1.18M	-3.48M	-0.67M	-0.61M	1.08M	-1.30M	0.06M	-0.13M	0.06M	0.34M	-0.82M	1.35M	0.02M	-1.44M	1.63M	-1.15M	5.91M
Change in Accured Expenses (Quarter)	-4.18M	-0.11M	-1.97M	-2.89M	-2.12M	-0.29M	-1.36M	-0.84M	0.03M	0.24M	-1.40M	-0.38M	0.09M	0.82M	-0.42M	-0.00M	1.08M	-0.60M	0.27M	0.70M
Investing Activities
Capital Expenditures (Quarter)	0.10M		0.04M	0.01M		0.05M	0.08M	0.14M			0.02M	0.04M	0.04M	0.05M	0.13M	0.15M	0.13M	0.07M	0.00M
Sales of Property, Plant and Equipment (Quarter)					0.04M	0.04M		0.09M
Change in Acquisitions & Divestments (Quarter)	18.91M	11.38M	23.97M	22.38M	12.01M	21.11M	27.00M	13.28M	22.12M	49.12M	26.70M	48.24M	41.49M	10.99M	11.00M	13.00M	18.00M	14.00M	13.00M	12.00M
Cash from Investing Activities (Quarter)	5.62M	0.77M	20.92M	13.41M	-5.25M	-8.83M	18.67M	5.54M	-20.32M	3.63M	5.39M	8.91M	-4.98M	7.11M	10.87M	10.90M	6.04M	-1.78M	8.07M	12.00M
Financing Activities
Other financing activities (Quarter)	0.67M	4.71M	0.99M	0.01M	0.12M	0.01M		0.06M	0.03M	0.01M	0.06M	0.19M	0.04M			0.09M	0.10M		0.04M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Short-Term Debt issuances (Quarter)																				5.54M
Change in Capital Stock
Shares Issued (Quarter)	4.98M	0.68M	5.57M	6.22M	3.74M	2.50M	3.74M	0.47M	3.14M	0.46M	2.33M	1.21M			7.41M		1.80M	0.13M	0.02M	1.28M
Net Equity Issued and Repurchased (Quarter)				0.61M
Misc.
Cash from Financing Activities (Quarter)	0.67M	4.71M	0.99M	0.62M	0.11M	-0.01M	-0.02M	0.05M	0.03M	0.01M	0.06M	0.19M	0.04M	-5.00M		0.09M	14.41M	1.38M	2.03M	9.44M
Exchange Rate Effect (Quarter)		0.03M	0.03M	-0.10M	-0.08M	0.41M	-0.04M	0.11M	0.06M	0.15M	-0.25M	0.31M	-0.24M	-0.06M	0.22M	0.17M	0.02M	-0.04M	-0.27M	-1.46M
Change in Cash (Quarter)	-11.27M	-11.84M	7.52M	-2.16M	-20.64M	-15.12M	12.77M	2.13M	-24.06M	-1.02M	-0.88M	1.06M	-13.92M	-5.21M	3.54M	1.56M	9.05M	-10.37M	-0.64M	12.35M
Free Cash Flow (Quarter)	-17.66M	-17.34M	-14.46M	-16.10M	-15.41M	-6.75M	-5.91M	-3.71M	-3.83M	-4.82M	-6.10M	-8.39M	-8.78M	-7.31M	-7.68M	-9.75M	-11.54M	-10.00M	-10.48M	-7.63M
Net Cash Flow (Quarter)	-11.27M	-11.87M	7.49M	-2.06M	-20.56M	-15.53M	12.81M	2.02M	-24.12M	-1.17M	-0.63M	0.75M	-13.68M	-5.16M	3.31M	1.38M	9.04M	-10.33M	-0.38M	13.82M

Research Tools

Datasets

Plans

Developers

Quince Therapeutics QNCX Cash Flow Statement (2018-2026)

Research Tools

Datasets

Plans

Developers

Quince Therapeutics QNCX Cash Flow Statement (2018-2026)

Create an account

Sign In

Reset Password